Atossa Therapeutics Launches COVID-19 HOPE Drug Development Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Atossa Therapeutics Launches COVID-19 HOPE Drug Development Program
ATOSSA GNTCS (NASDAQ: ATOS) Delayed: 2.46 -0.13 (5.02%)
Previous Close $2.59    52 Week High $3.64 
Open $2.57    52 Week Low $0.14 
Day High $2.70    P/E N/A 
Day Low $2.45    EPS $0.00 
Volume 644,599